IGE025

· Novartis

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IGE025, covering 2011-10-25 to 2011-10-25. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma. [Phase 3]